Both in Pharmaceuticals
AbCellera Biologics vs Arcutis Biotherapeutics
Over the past year ABCL returned +111.1% and ARQT returned +28.7%; their daily moves had a correlation of 0.26.
ABCL +111.1% ARQT +28.7%Growth of $1, one year, split-adjusted
| Metric | ABCL | ARQT |
|---|---|---|
| Price | $11.34 | $31.86 |
| Market cap | $3.67B | $4.00B |
| Today | −7.62% | −0.65% |
| 1 month | −17.5% | +26.6% |
| 6 months | +146.9% | +35.6% |
| Year to date | +231.4% | +9.7% |
| 1 year | +111.5% | +27.8% |
| Revenue growth (YoY) | −76.3% | +59.3% |
| Gross margin | 100.0% | 91.6% |
| Net margin | −1368.6% | 11.6% |
| P/E (TTM) | — | 140.4× |
| Price / sales | 55.5× | 8.6× |
| Net cash | $540.1M | $129.7M |
| Dividend yield | — | — |
| Volatility (60d) | 96.1% | 53.2% |
| Short % of float | 14.5% | 18.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).